Navigation Links
ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
Date:11/10/2010

e in a class by itself.  We think that this new agent has extraordinary potential in treating previously intractable conditions such as the devastating vasculitis seen in autoimmune diseases."

CCX168 Study Results and ANCA-Associated Vasculitis

In Phase I clinical trials CCX168 was safe and well tolerated, with excellent oral bioavailability and dose-proportional exposure increases in human subjects.  Pharmacokinetic and pharmacodynamic data indicated that 30 to 50 mg of CCX168 given orally twice daily in humans results in greater than 90% C5aR coverage in blood at all times, and this is considered optimal for CCX168 evaluation in Phase II trials in vasculitis.

Supporting the Phase I data are results from a mouse model of anti-neutrophil cytoplasmic autoantibody (ANCA) associated glomerulonephritis (GN).  In this study, human C5aR transgenic mice were employed, and ANCA kidney disease was profoundly inhibited by doses of CCX168 that are very similar to those achieved safely in the human Phase I studies.

CCX168 is a highly potent and very selective compound that specifically targets the receptor for the anaphylotoxin designated C5a, a component of the body's complement system and a potent driver of the inflammatory response associated with ANCA-associated vasculitis and other autoimmune disease. In ANCA disease, auto-antibodies lead to the activation and increased adhesiveness of neutrophils to endothelial cells that line the interior surfaces of blood vessels in the kidney and other organs.  These adhering neutrophils accumulate inside the blood vessels and initiate an inflammatory cascade.  Activation of the complement pathway occurs as a consequence, with production of C5a, one of the most potent pro-inflammatory mediators of the complement system.  C5a, through binding to its receptor C5aR, induces expression of additional adhesion molecules and chemotactic factors, thus
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
2. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
6. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
7. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
8. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
9. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
10. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... About dry eye syndrome Dry eye syndrome usually ... production or quick tear evaporation or deviation in tear ... deficient dry eye and evaporative dry eye. In aqueous ... enough tears, whereas meibomian gland dysfunction results in evaporative ... evaporation and maintain tear stability. The symptoms include pain, ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
(Date:9/3/2015)... , Sep. 03, 2015 ... addition of the "Investigation Report on China,s Entecavir ... The number of people infected with hepatitis B virus ... , among which 20-30 million suffering from chronic Hepatitis ... of liver damage and liver cancer caused by chronic ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6China Entecavir Market Report 2010-2019 2
... 18, 2011 Insource Spend Management Group, a ... announced it has hit a milestone of exceeding ...  Many Fortune 500 clients have individually saved tens ... software, analytics and expert negotiation. Shippers across a ...
... Kensey Nash Corporation (NASDAQ: KNSY ), a ... wide range of medical procedures, today reported the results for ...   Fourth Quarter Snapshot and Recent Developments ... which includes net Norian acquisition items, see discussion below, compared ...
Cached Medicine Technology:Insource Saves Clients Over $1 Billion on Parcel Shipping 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 14Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 15Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 16Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 17Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 18Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 19Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 20Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results 21
(Date:9/4/2015)... , ... September 04, 2015 , ... ... medical assistance company today announced that it has entered into a multi-year agreement ... signed an agreement to bridge the link between American healthcare, Jamaican healthcare and ...
(Date:9/3/2015)... ... 04, 2015 , ... AlignLife of Wauwatosa is excited to hold ... many children and adults who don't have the ability to buy a jacket warm ... our annual Coat Drive to help those in need." , This is AlignLife's third ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Allied Anesthesia ... where innovative medicine is the norm not the exception. , St. Jude was recently ... American Heart Association/American Stroke Association, making it one of only 10 hospitals in the ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Inc. , a privately held medical technology company that will bring low-cost cancer ... markets worldwide. , Preora’s proprietary and automated technology platform detects and measures ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Oregon Collaborative ... of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in Integrative Health & Medicine. ... MD, an internationally renowned educator, physician and thought leader in integrative medicine. This ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3
... Wellmont will be ... ... with Delaine Anderson, and it,s clear she does not shrink from life,s challenges. She has spent ... the country before that. She even lived seven years in Greece, where she didn,t speak the ...
... , , , ... NBIX ) announced today that Kevin Gorman, President and Chief ... Partners Healthcare Conference in Boston. , , The ... Time (ET)/6:45 a.m. Pacific Time (PT). The presentation will be simultaneously ...
... don,t eat right, study suggests , WEDNESDAY, Sept. 2 ... but who don,t follow a Mediterranean-style diet are more ... , Italian researchers asked patients who,d been recently diagnosed ... their dietary habits, including caffeine consumption. Their diets were ...
... Tenn., Sept. 2 HCA today announced Dr. Richard Tayrien will ... September 21. , , (Logo: ... 56, will report to Dr. Jonathan B. Perlin, President of HCA,s ... expanding team of clinicians and informaticists and be responsible for the ...
... , , WASHINGTON, Sept. 2 ... or H1N1 outbreak, in a recent article . , ... the Mexican government in the fields of public awareness, rapid diagnosis, ... , The article noted "Mexico,s most effective action -- ...
... , , AVENTURA, Fla., Sept. 2 ... today announced Margaret Lewin MD, as the company,s chief medical director. ... on health care issues, ranging from new scientific studies and emerging ... , "We are excited to have Dr. Lewin ...
Cached Medicine News:Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 2Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 3Health News:Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer 4Health News:Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2Health News:Caffeine Without Healthy Diet Linked to Heart Risk 2Health News:HCA Appoints Dr. Richard Tayrien Chief Health Information Officer 2Health News:Cinergy Health Names Dr. Margaret Lewin Chief Medical Director 2
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Inquire...
... inspired by the professional male who enjoys buying ... by all men especially those between the ages ... complete range of materials, shapes and colors. Classic ... the best that fashion and technology has to ...
Medicine Products: